| May 1, 2023 | Boundless Bio | $100.0M Series C | Fabio Pucci, RA Capital Management | ARCH Venture Partners, Nextech Invest, RA Capital, SignalFire, Versant Ventures, Alexandria Venture Investments, City Hill Ventures, Fidelity Management & Research Company, Logos Capital, Nextech Invest, PFM Health Sciences, Piper Heartland Healthcare Capital, Redmile Group, Sectoral Asset Management, Surveyor Capital, Vertex Ventures HC, Wellington Management |
| May 1, 2023 | Moon Surgical | $55.0M Series B | Soffinova Partners, Mohamed (Sid) Siddeek | 99 Startups, Ascension Ventures, Cathay Health, Endeavor Venture Funds, Gradient Ventures, Nazca Ventures, New Enterprise Associates (NEA), Jenny Johnston, Sonder Capital, Colin Cahill, Maurice Ferre, Michael Shoemaker, Fred Moll, M.D, Josh Makower, Richard Leparmentier, Sacha Loiseau, Siddarth Satish, Yann Fleureau, Stephen Oesterle, Johnson & Johnson Innovation |
| Jun 1, 2022 | Moon Surgical | $31.0M Series A | Alan Au | 99 Startups, Ascension Ventures, Cathay Health, Endeavor Venture Funds, Gradient Ventures, Nazca Ventures, New Enterprise Associates (NEA), Jenny Johnston, Soffinova Partners, Sonder Capital, Colin Cahill, Maurice Ferre, Michael Shoemaker, Richard Leparmentier, Sacha Loiseau, Siddarth Satish, Yann Fleureau, Cathay Capital, Fred Moll, M.D |
| Apr 27, 2021 | Exscientia | $225.0M Series D | SoftBank Vision Fund 2 | BlackRock, Bristol Myers Squibb, Casdin Capital, Andrew Hopkins, Farallon Capital Management, Hongkou, Laurion Capital Management, Marshall Wace, Novo Holdings, Pivotal bioVenture Partners |
| Apr 1, 2021 | Boundless Bio | $110.0M Series B | Jakob Loven, Zach Scheiner | ARCH Venture Partners, Nextech Invest, RA Capital, SignalFire, Versant Ventures, Alexandria Venture Investments, Boxer Capital, City Hill Ventures, Fidelity Management & Research Company, Logos Capital, PFM Health Sciences, Redmile Group, Surveyor Capital, Vertex Ventures HC, Wellington Management |
| Mar 4, 2021 | Exscientia | $100.0M Series C | — | William Abecassis, Bristol Myers Squibb, Evotec, Novo Holdings |
| Aug 1, 2020 | G.I. Windows | $16.0M Series A | — | Sonder Capital, John Cammett, Johnson & Johnson Innovation, Kennedy Trust |
| May 26, 2020 | Exscientia | $60.0M Series C | Robert Ghenchev | Bristol Myers Squibb, Evotec |
| Feb 12, 2020 | Oxford VR | $12.9M Series A | Ashish Patel | Isabel Fox, Oxford Science Enterprises, Oxford University |
| Dec 1, 2019 | G.I. Windows | $15.0M Series A | Sonder Capital, Alan Au | — |
| Sep 1, 2019 | Boundless Bio | $46.0M Series A | ARCH Venture Partners, City Hill Ventures | Nextech Invest, RA Capital, SignalFire, Alexandria Venture Investments, Boxer Capital, Carolyn Ng |
| Jan 7, 2019 | Exscientia | $26.0M Series B | — | Celgene, Evotec |
| Jul 10, 2018 | Potrero Medical | $26.6M Series C | GT Healthcare Capital Partners, Sonder Capital | — |
| May 1, 2018 | Ultromics | $13.0M Series A | Oxford Science Enterprises | 24Haymarket, Andre Crawford-Brunt, Dieter Spälti, Muang Thai Fuchsia Ventures, Neptune, RT Ventures, Tanarra Capital |
| Apr 1, 2018 | RefleXion Medical | $100.0M Series C | — | ALSA Ventures, Ascension Ventures, Soffinova Partners, Johnson & Johnson Innovation, KCK Group, T. Rowe Price Associates, Venrock |
